![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety Pharmacokinetics and Efficacy of Dolutegravir in Treatment Experienced HIV + Children
|
|
|
Reported by Jules Levin
CROI 2014 March 3-6
Boston, MA
Rolando M. Viani1, Carmelita Alvero2, Terry Fenton2, Edward Acosta3, Rohan Hazra4, Ellen O'Gara5, Barb Heckman6, Debra Steimers7, Sherene Min7, Andrew Wiznia8, and the P1093 Team
1University of California San Diego, CA, 2Harvard School of Public Health, MA, 3University of Alabama at Birmingham, AL, 4NICHD, MD, 5NIAID, MD, 6Frontier Sciences Research Foundation Inc, NY, 7GlaxoSmithKline, NC, 8Jacobi Medical Center, NY, USA
![CROI1.gif](../images/040114/040114-3/CROI1.gif)
![CROI2.gif](../images/040114/040114-3/CROI2.gif)
![CROI3.gif](../images/040114/040114-3/CROI3.gif)
![CROI4.gif](../images/040114/040114-3/CROI4.gif)
![CROI5.gif](../images/040114/040114-3/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|